AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...
In a phase 2b trial, nearly 100% of patients treated with SAP-001 at the 30mg and 60mg doses achieved the target serum uric acid level of less than 6mg/dL. The Food and Drug Administration (FDA) has ...
Add Yahoo as a preferred source to see more of our stories on Google. If you often find yourself sidelined by a sudden, throbbing pain in your joints, especially in your big toe, you may be suffering ...
Gout affects around 9 million Americans, and around 50% of those with gout will have their first attacks begin in the big toe. The severity of gout will depend on the individual, but, on average, ...
Courtney Southwick is a writer focusing on health, nutrition, and disease. She has been blogging for the past two years at CourtneySouthwick.com. She writes blogs and articles for online publications ...
Gout could be treated by an ancient gene that humans lost millions of years ago, suggests new research. A form of arthritis caused by crystals that build up in joints and cause swelling and pain, gout ...
NEWTON, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a late-stage biopharmaceutical company deploying its novel oral biologic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results